ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA

Clinical trials for ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA trials appear

Sign up with your email to follow new studies for ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to halt advanced cancers

Disease control Recruiting now

This study tests an experimental drug called SPH4336, given alone or with another drug (cadonilimab), in people with advanced solid tumors that cannot be removed by surgery. The goal is to see if the treatment can slow or stop cancer growth. About 63 participants will take part i…

Matched conditions: ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA

Phase: PHASE1, PHASE2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control

Last updated Jun 05, 2026 12:08 UTC

ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA

Get alerted when new ADVANCED WELL DIFFERENTIATED/DEDIFFERENTIATED LIPOSARCOMA trials appear

New drug duo aims to halt advanced cancers